Pancreatic Cancer - Pipeline Review, H2 2015

Pancreatic Cancer - Pipeline Review, H2 2015

Code: GMDHC7415IDB | Published: Dec-2015 | Pages: 1769 | Global Markets Direct
Price :

* Required Fields



Pancreatic Cancer - Pipeline Review, H2 2015


Global Markets Directs, Pancreatic Cancer - Pipeline Review, H2 2015, provides an overview of the Pancreatic Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

3-V Biosciences, Inc.
3B Pharmaceuticals GmbH
AB Science SA
AbbVie Inc.
AbGenomics International, Inc.
Ability Pharma, SL
Acetylon Pharmaceuticals, Inc.
ACF Pharmaceuticals, LLC
Adamed Sp. z o.o.
Adamis Pharmaceuticals Corporation
Aduro BioTech, Inc.
Advantagene, Inc.
Advaxis, Inc.
Agenus, Inc.
AGV Discovery, SAS
AIMM Therapeutics B.V.
Alchemia Limited
Alethia Biotherapeutics Inc.
Allinky Biopharma
Almac Discovery Limited
Altor BioScience Corporation
Ambrx, Inc.
Amgen Inc.
Anavex Life Sciences Corp.
Andarix Pharmaceuticals, Inc.
ANP Technologies, Inc.
APEIRON Biologics AG
Apexigen, Inc.
Aphios Corporation
APIM Therapeutics AS
Apogenix GmbH
Aposense Ltd.
Arch Biopartners, Inc.
Argon Pharma S.L.
ArQule, Inc.
Array BioPharma Inc.
Ascenta Therapeutics, Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Aurigene Discovery Technologies Limited
AVEO Pharmaceuticals, Inc.
Axcentua Pharmaceuticals AB
Azaya Therapeutics, Inc.
Basilea Pharmaceutica AG
Bavarian Nordic A/S
Bayer AG
Bellicum Pharmaceuticals, Inc.
BerGenBio AS
Beta Pharma, Inc.
Bexion Pharmaceuticals, LLC.
Biomar Microbial Technologies
Biomunex Pharmaceuticals
Bioncotech Therapeutics S.L.
Bionomics Limited
BiOrion Technologies B.V.
Biotest AG
Biothera, Inc.
Biouniversa s.r.l.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Calithera Biosciences, Inc.
Cantex Pharmaceuticals, Inc.
Cavion LLC
Celgene Corporation
Cellectar Biosciences, Inc.
Cellectis S.A.
Celsion Corporation
Centrose LLC
Ceronco Biosciences
ChemoCentryx, Inc.
Chiome Bioscience, Inc.
Clovis Oncology, Inc.
Coare Biotechnology, Inc.
Concordia Healthcare Corp.
Confluence Life Sciences, Inc.
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CritiTech, Inc.
CrystalGenomics, Inc.
CTI BioPharma Corp.
CureFAKtor Pharmaceuticals, LLC
Cyclacel Pharmaceuticals, Inc.
CytomX Therapeutics, Inc.
CytoVac A/S
CytRx Corporation
CyTuVax B.V.
Daewoong Pharmaceutical Co., Ltd.
Dicerna Pharmaceuticals, Inc.
e-Therapeutics Plc
Eisai Co., Ltd.
Eleison Pharmaceuticals LLC
Eli Lilly and Company
Endor Nanotechnologies SL
Ensol Biosciences Inc.
Erytech Pharma SA
Esperance Pharmaceuticals, Inc.
Etubics Corporation
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
FibroGen, Inc.
Five Prime Therapeutics, Inc.
Fountain Biopharma Inc.
Fujifilm Corporation
Fusion Antibodies Limited
Ganymed Pharmaceuticals AG
Genelux Corporation
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Globeimmune, Inc.
GlycoMimetics, Inc.
Golden Biotechnology Corp.
Halozyme Therapeutics, Inc.
HanAll Biopharma Co., Ltd.
Heat Biologics, Inc.
HEC Pharm Co., Ltd.
Helix BioPharma Corp.
Huabo Biopharm Co., Ltd.
iCeutica, Inc.
Ignyta, Inc.
Immodulon Therapeutics Ltd.
Immune Pharmaceuticals Inc.
Immunomedics, Inc.
Immunotope, Inc.
Immunovo BV
Incuron, LLC
Incyte Corporation
Inflection Biosciences Limited
Innopharmax Inc.
Inovio Pharmaceuticals, Inc.
Intica Biomedical, Inc.
Inventiva SAS
Io Therapeutics, Inc.
Ipsen S.A.
Isarna Therapeutics GmbH
Jasco Pharmaceuticals, LLC.
Jiangsu Hengrui Medicine Co., Ltd.
Kadmon Corporation, LLC
KAEL-GemVax Co., Ltd.
Kalos Therapeutics, Inc.
Kancera AB
Karyopharm Therapeutics, Inc.
Keystone Nano, Inc.
Komipharm International Co., Ltd.
Kura Oncology, Inc.
LivTech, Inc.
Lymphocyte Activation Technologies, S.A.
MabVax Therapeutics Holdings, Inc.
MacroGenics, Inc.
Meabco A/S
Mebiopharm Co., Ltd.
MediaPharma s.r.l.
Medicenna Therapeutics, Inc
MedImmune, LLC
Medivation, Inc.
Merck & Co., Inc.
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Monopar Therapeutics LLC
Morphotek, Inc.
MSM Protein Technologies, Inc.
Multimmune GmbH
NanoCarrier Co., Ltd.
Nanotherapeutics, Inc.
NantKwest, Inc.
Natco Pharma Limited
NatureWise Biotech & Medicals Corporation
NeoPharm Co., Ltd.
Nerviano Medical Sciences S.r.l.
NewLink Genetics Corporation
NormOxys, Inc.
Northwest Biotherapeutics, Inc.
Novartis AG
NuCana BioMed Limited
Omeros Corporation
Omnitura Therapeutics Inc.
Oncodesign SA
Oncodrone BV
Oncology Research International Limited
Oncolytics Biotech Inc.
Oncomatryx Biopharma, S.L.
OncoMed Pharmaceuticals, Inc.
Oncothyreon Inc.
Oncovir, Inc.
Ono Pharmaceutical Co., Ltd.
Optimum Therapeutics, LLC
Oryx GmbH & Co. KG
Oscotec Inc.
Otsuka Holdings Co., Ltd.
Pfizer Inc.
Pharma Mar, S.A.
Pharma Two B Ltd
PharmAbcine, Inc.
Pharmacyclics, Inc.
PharmaCyte Biotech, Inc.
Pharmedartis GmbH
Phoenix Biotechnology, Inc.
Pique Therapeutics
Plexxikon Inc.
Polaris Pharmaceuticals, Inc.
Precision Biologics, Inc.
Prescient Therapeutics Limited
Prima BioMed Ltd.
ProMetic Life Sciences Inc.
Qu Biologics Inc.
Quest PharmaTech Inc.
Quimatryx, S.L.
Raptor Pharmaceutical Corp.
RedHill Biopharma Ltd.
Redx Pharma Plc
Rexahn Pharmaceuticals, Inc.
Rigontec GmbH
Samyang Holdings Corporation
Sareum Holdings Plc
Savoy Pharmaceuticals, Inc.
SignPath Pharma Inc
Silence Therapeutics Plc
Sillajen Biotherapeutics
Sorrento Therapeutics, Inc.
Strongbridge Biopharma plc
Sumitomo Dainippon Pharma Co., Ltd.
Sunesis Pharmaceuticals, Inc.
Symphogen A/S
Synovo GmbH
Synta Pharmaceuticals Corp.
Taiho Pharmaceutical Co., Ltd.
Taiwan Liposome Company, Ltd.
Takara Bio Inc.
Takeda Pharmaceutical Company Limited
Tara Immuno-Oncology Therapeutics LLC
Targovax AS
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Limited
TG Therapeutics, Inc.
Tokai Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc.
Transgene SA
TVAX Biomedical, Inc.
Tyg Oncology Ltd.
Tyrogenex, Inc.
ValiRx Plc
VasGene Therapeutics, Inc.
Vaxeal Holding SA
Vaximm AG
Vaxon Biotech
VCN Biosciences SL
Vect-Horus S.A.S.
Verlyx Pharma Inc.
Vertex Pharmaceuticals Incorporated
Vicus Therapeutics, LLC
Virobay Inc.
Welichem Biotech Inc.
Wilex AG
XOMA Corporation
XTuit Pharmaceuticals, Inc.
Zeria Pharmaceutical Co., Ltd.
Zhejiang BetaPharma Co., Ltd.
Zymeworks Inc.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]

2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal

3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at


There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
Global Markets Direct

Our Clients